v3.25.1
Stockholders' Equity
3 Months Ended
May 03, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

7. Stockholders’ Equity

 

Equity-Based Compensation

Equity-based compensation awards under the Company’s current equity incentive plan (as amended, the “2021 Equity Incentive Plan”) include restricted stock units (“RSUs,” which include performance-based stock units and market-based stock units), restricted stock awards (“RSAs”), non-qualified stock options, and other equity compensation awards. In addition, the Company has made equity-based compensation awards of RSUs and non-qualified stock options outside of the 2021 Equity Incentive Plan as employment inducement awards (collectively, the “Inducement Awards”). The Company also has an employee stock purchase plan (“ESPP”).

The Company’s controlling parent, Scooby LP, also maintains an incentive plan (the “2016 Incentive Plan”) under which it has awarded partnership unit awards to certain current and former employees, consultants, and non-employee directors of the Company that are restricted profit interests in Scooby LP subject to a distribution threshold (“Series C Units”).

The following table summarizes the Company’s equity-based compensation expense by award type (in thousands):

 

 

 

Thirteen weeks ended

 

 

 

May 3,
2025

 

 

May 4,
2024

 

RSUs and RSAs

 

$

7,735

 

 

$

10,722

 

Options

 

 

1,365

 

 

 

5,553

 

ESPP

 

 

338

 

 

 

320

 

Other awards

 

 

(18

)

 

 

839

 

Total equity-based compensation expense

 

$

9,420

 

 

$

17,434

 

 

Activity under the 2021 Equity Incentive Plan and the Inducement Awards was as follows (shares and dollars in thousands):

 

 

 

RSUs and RSAs

 

 

Options

 

Nonvested/outstanding, February 1, 2025

 

 

12,180

 

 

 

11,685

 

Granted

 

 

14,879

 

 

 

3,050

 

Vested and delivered/exercised

 

 

(2,258

)

 

 

 

Forfeited/expired

 

 

(971

)

 

 

(380

)

Nonvested/outstanding, May 3, 2025

 

 

23,830

 

 

 

14,355

 

Unrecognized compensation expense as of May 3, 2025

 

$

58,766

 

 

$

13,325

 

Weighted average remaining expense period as of May 3, 2025

 

2.4 years

 

 

2.4  years

 

 

The ESPP allows eligible employees to contribute up to 15% of their base earnings towards purchases of Class A common stock, subject to an annual maximum. The purchase price will be 85% of the lower of (i) the fair market value of the stock on the associated lookback date and (ii) the fair market value of the stock on the last day of the related purchase period.

Series C Unit activity under the 2016 Incentive Plan was as follows (in thousands):

 

 

 

Units

 

Outstanding, February 1, 2025

 

 

192,835

 

Granted

 

 

 

Forfeited

 

 

(409

)

Outstanding, May 3, 2025

 

 

192,426

 

Vested, May 3, 2025

 

 

190,382

 

No additional Series C Units have been or will be awarded following the Company’s initial public offering. As of May 3, 2025, unrecognized compensation expense related to the unvested portion of Scooby LP’s Series C Units was $0.1 million, which is expected to be recognized over a weighted average period of 0.3 years. In addition to acceleration upon a change in control, a portion of grantees’ Series C Units may vest upon certain levels of direct or indirect sales by Scooby LP of the Company’s Class A common stock, and all unvested Series C Units will fully accelerate in the event Scooby LP sells 90% of its direct or indirect holdings of the Company’s Class A common stock.

Loss Per Share

Potentially dilutive securities include potential Class A common shares related to outstanding stock options, unvested RSUs and RSAs, and the ESPP, calculated using the treasury stock method. The calculation of diluted shares outstanding excludes securities where the combination of the exercise or purchase price (in the case of options and the ESPP) and the associated unrecognized compensation expense is greater than the average market price of Class A common shares because the inclusion of these securities would be anti-dilutive.

All outstanding equity awards were excluded from the calculation of diluted loss per Class A and B-1 common share in the thirteen weeks ended May 3, 2025 and May 4, 2024, as their effect would be antidilutive in a net loss period.